Multiple effects of arginine vasopressin on prostaglandin E2 synthesis in fibroblasts

European Journal of Pharmacology

Volumn 485, Issue 1-3, 2004, Pages 53-59

  Sigal, Fleisher Berkovich ^a   Elena, Kagan ^a,b   Nili, Grossman ^a   Abraham, Danon ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEVA PHARMACEUTICALS   (Israel)

Author keywords

Inflammation; Interleukin 1; Prostaglandin; Vasopressin

Indexed keywords

1 [5 ETHOXY 3 SPIRO [4 (2 MORPHOLINOETHOXY)CYCLOHEXANE]INDOLIN 2 ONE; ARGIPRESSIN; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; RELCOVAPTAN; SR 121463B; UNCLASSIFIED DRUG; VASOPRESSIN RECEPTOR ANTAGONIST;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SKIN FIBROBLAST;

EID: 1642538385     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.11.049     Document Type: Article

References (30)

1. Antoni F. Hypothalamic control of adrenocorticotropin: advances since the discovery of the 41-residue corticotropin releasing factor. Endocr. Rev. 7:1986;351-378.
2. Cooper C.L., Malik K.U. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors. J. Pharmacol. Exp. Ther. 229:1984;139-147.
3. Croiset G., Heijnen C.J., De Wied D. Passive avoidance behaviour, vasopressin and the immune system. A link between avoidance latency and immune response. Neuroendocrinology. 51:1990;156-161.
4. Fuchs A.R., Werner R., Fields M.J. Accumulation of cyclooxygenase-2 gene transcripts in uterine tissues of pregnant and parturient cows: stimulation by oxytocin. Biol. Reprod. 60:1999;341-348.
5. Geenen V., Legros J.J., Franchimont P., Defresne M.P., Boniver J., Ivell R., Richter D. The thymus as a neuroendocrine organ: synthesis of vasopressin and oxytocin in human thymic epithelium. Ann. N.Y. Acad. Sci. 496:1987;56-66.
6. Jansky L. A discrete mode of the anti-pyretic action of AVP, MSH and ACTH. Physiol. Res. 41:1992;57-61.
7. Jessop D.S., Chowdrey H.S., Lightman S.L., Larsen P.J. Vasopressin is located within lymphocytes in the rat spleen. J. Neuroimmunol. 56:1995;219-223.
8. Johnson H.M., Farrar W.L., Torres B. Vasopressin replacement of interleukin-2 requirement in gamma interferon production: lymphokine activity of a neuroendocrine hormone. J. Immunol. 129:1982;983-986.
9. Liberthal W., Levine L. Stimulation of prostaglandin production in rat glomerular epithelial cells by antidiuretic hormone. Kidney Int. 25:1984;766-770.
10. Markwick A.J., Lolait S.J., Funder J.W. Immunoreactive vasopressin in rat thymus. Endocrinology. 119:1986;1690-1696.
11. Michell R.H., Kirk C.J., Billah M.M. Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem. Soc. Trans. 7:1979;861-865.
12. Murase T., Kozawa O., Miwa M., Tokuda H., Kotoyori J., Kondo K., Oiso Y. Regulation of proliferation by vasopressin in aortic smooth muscle cells: function of protein kinase C. J. Hypertens. 10:1992;1505-1511.
13. 2 production. Prostaglandins Leukot. Essent. Fat. Acids. 58:1998;157-162.
14. Nishikori T., Irie K., Suganuma T., Ozaki M., Yoshioka T. Anti-inflammatory potency of FR167653, a p38 mitogen-activated protein kinase inhibitor, in mouse models of acute inflammation. Eur. J. Pharmacol. 451:2002;327-333.
15. Okamura T., Toda M., Ayajiki K., Toda N. Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries. J. Vasc. Res. 34:1997;464-472.
16. Pang G., Cough L., Batey R., Clancy R., Cripps A. GM-CSF, interleukin-1 alpha, interleukin-1 beta, interleukin-6, interleukin-8, interleukin-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, interleukin-1 alpha and TNF alpha. Clin. Exp. Immunol. 96:1994;437-443.
17. Patchev V.K., Kalogeras K.T., Zelazowski P., Wilder R.L., Chrousos G.P. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin releasing hormone-deficient Lewis rats. Endocrinology. 131:1992;1453-1457.
18. Patchev V.K., Mastoracos G., Brady L.S., Redwine J., Wilder R.L., Chrousos G.P. Increased arginine vasopressin secretion may participate in the enhanced susceptibility of Lewis rats to inflammatory disease. Neuroendocrinology. 58:1993;106-110.
19. Rivier C., Rivier J., Mormade P., Vale W.W. Studies on the nature of the interaction between vasopressin and corticotropin releasing factor on adrenocorticotropin release in rat. Endocrinology. 115:1984;882-886.
20. Saper C.B., Breder C.D. The neurologic basis of fever. N. Engl. J. Med. 330:1996;1880-1886.
21. Scharschmidt L.A., Dunn M.J. Prostaglandin synthesis by rat glomerular mesangial cells in culture. Effects on angiotensin II and arginine vasopressin. J. Clin. Invest. 71:1983;1756-1764.
22. Smith R.S., Smith T.J., Blieden T.M., Phipps R.P. Fibroblasts as sentinel cells; synthesis of chemokines and regulation of inflammation. Am. J. Pathol. 151:1997;317-322.
23. Suzuki T., Segami N., Nishimura M., Nojima T. Co-expression of interleukin-1β and tumor necrosis factor α in synovial tissues and synovial fluids of temporomandibular joint with internal derangement: comparision with histological grading of synovial inflammation. J. Oral Pathol. & Med. 31:2002;549-557.
24. 1-vascular vasopressin receptors. Regul. Pept. Rev. 38:1992;1-11.
25. 1 receptor in cultured rat mesangial cells. Am. J. Physiol., Renal Physiol. 276:1999;433-441.
26. Valloton M.B., Gerber-Wicht C., Dolci W., Wuthrich R.P. Interaction of vasopressin and angiotensin II in stimulation of prostacyclin synthesis in vascular smooth muscle cells. Am. J. Physiol. 257:1989;617-624.
27. 2 and cyclic AMP response to vasopressin in renal medullary tubular cells. Am. J. Physiol. 251:1986;499-505.
28. Yang Y., Huang W., Lu X. Early changes of endothelin, nitric oxide and arginine-vasopressin in patients with acute cerebral injury. Chin. J. Traumatol. 5:2002;259-262.
29. Yirmiya R., Shavit Y., Ben-Eliyahu S., Martin F.C., Weiner H., Leibeskind J.C. Natural killer activity in vasopressin-deficient rats. Brain Res. 479:1989;16-22.
30. 2 excretion in man. J. Clin. Endocrinol. Metab. 53:1981;522-526.